MEA Infusion Pump Market

MEA Infusion Pump Market Size (2022 to 2027)

The Middle East and Africa infusion pump market size is estimated to be growing at a steady CAGR during the forecast period.

The MEA infusion pump market has seen significant development in recent years and is expected to grow significantly during the forecast period. For the most part, infusion pumps are used in hospitals and other human service companies to deliver drugs and fluids to a patient's body in a controlled manner. These infusion pumps improve the care of patients under the control of narcotics, pain relievers, antibiotics, and more. Infusion sets are useful tools for administering drugs and fluids such as saline, dextrose, and plasma solutions. In addition, there is a growing interest in volume infusion for hydration therapy, and parenteral nutrition is driving the development of the MEA infusion pump market.

Several circumstances, such as the increasing incidence of chronic diseases associated with the accelerated growth of the geriatric population, the increasing demand for ambulatory infusion pumps, and the increasing volume of surgical methods performed, are driving the infusion pump market. R&D in the insulin segments is increasing year by year, and scientists are trying to find the best molecule for use by patients, limiting peak side effects and increasing its effectiveness.

People with type 1 diabetes need insulin therapy, and treatment focuses on controlling blood sugar levels with insulin, diet, and lifestyle to prevent complications. In addition, untapped developing companies such as Egypt, Zimbabwe and the increasing adoption of convenient infusion pumps provide significant growth opportunities for major companies operating in this region.

However, the high cost of implantable devices is hampering the growth of the global infusion pump market.

Furthermore, taking advantage of unmet needs is expected to create lucrative opportunities for major players to earn higher incomes. Dosing errors, which can be initiated by the user or due to neglect of parts of the infusion pump, remain the main drawbacks observed in the management of the infusion pump. The increasing adoption of refurbished and rental infusion pumps and the stringent regulatory requirements for new products are the major factors that will hamper the market growth and further challenge the growth of the infusion pump market period mentioned above.

Impact of COVID-19 on the MEA infusion pump market:

The demand for infusion pumps has increased dramatically due to the COVID-19 outbreak. With the increase in the number of infections worldwide, hospitals are facing a shortage of infusion pumps to treat COVID-19 patients using a nebulizer. As a result, governments have ordered thousands of infusion pumps from manufacturers. With the sudden increase in the demand for infusion pumps, domestic and international companies are increasing their production capacities to meet the growing demand, thus increasing the growth prospects.

This market research report on the Middle East and Africa Infusion pump market has been segmented and sub-segmented into the following categories.

 By Type:

• Accessories and Consumables
• Devices

By Product:

• Volumetric infusion pumps
• Insulin infusion pumps
• Enteral infusion pumps
• Ambulatory infusion pumps
• Syringe infusion pumps
• Patient-controlled analgesia (PCA) pumps
• Implantable infusion pumps

By Application:

• Chemotherapy/oncology
• Diabetes
• Gastroenterology
• Analgesia/pain management
• Pediatrics/neonatology
• Hematology
• Other applications

By End-User:

• Hospitals
• Home Care Settings
• Ambulatory Care Settings
• Academic And Research Institutes

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, Egypt has the highest market share in the insulin infusion pump market in the Middle East and Africa. As a result, Egypt holds the highest market share in the insulin infusion pump market in the Middle East and Africa. It is also expected to register a high CAGR of 5.2% during the forecast period. In Egypt, the cost of purchasing essential insulin for people with type 1 diabetes has been estimated at 58% of the average monthly disposable income.

The Middle East and Africa accounted for 72% and 28% of shares in the MEA market, respectively, in 2019.

The region is experiencing a steady growth in infusion pumps due to the growing geriatric population and the increasing prevalence of various lifestyle-related diseases. However, one of the major reasons for Middle East dominance in the MEA market is that insurance companies cover infusion pumps. This factor positively affects the growth of the market.

KEY MARKET PLAYERS:

A few of the notable companies operating in the MEA infusion pump market profiled in this report are Becton, Dickinson, and Company, Smiths Medical, Baxter International, Inc., Hospira, Inc., and New Era Pump Systems, Inc.